'Facebook flu' hits IPO market
IPOs have come to a standstill after the social network's notorious market debut.
None. The party is over after Facebook (FB) trashed the place. In fact, June is looking to be the driest month for initial public offerings in nine years, CNBC reports. Historically, June has been the No. 3 month for IPOs, behind October and November.
Post continues below.
Now, there isn't a direct link between Facebook's disastrous IPO and the barren month that followed. But you can't help but wonder how many hopeful CEOs watched Facebook's market debut -- and the numerous technical flubs over at Nasdaq -- with a few tears in their eyes.
CNBC is calling it the "Facebook flu," an apt description because there's no cure here. IPO-hungry execs just need to drink plenty of fluids and wait it out. The best medicine of all would be a smashingly successful IPO to help push Facebook back into the dark corners of the market's mind.
Only four deals are expected to be priced at the end of the month, and none are generating much excitement. We have EQT Midstream, a natural gas and energy company; Exa Corp, which makes engineering software; cancer drug maker Tesaro and cloud-software company ServiceNow.
ServiceNow, by the way, marks Morgan Stanley's return to the IPO market after it led Facebook's debut. Morgan Stanley and dozens of underwriters made an estimated $100 million in profit from Facebook's IPO, so it's not too disgruntled over the drama.
Facebook could help erase the black mark from its IPO with a stock upturn, and for a while Thursday, that appeared to be taking place. The stock soared out of the gate to approach $32.40, but fell back and closed with a gain of less than 1% to $31.84.
More from MSN Money
- Oracle CEO buys a Hawaiian island
- The iPhone's biggest rival debuts
- P&G's troubles start in the corner office
MORE ON MSN MONEY
DATA PROVIDERS
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.
LATEST POSTS
This young tech company has a can't-miss concept, but hasn't yet generated real sales. Should you see its recent slump as a buying opportunity, or reason to stay away?
FIDELITY VIEWPOINTS
- How to sell covered calls - Fidelity Investments
- Savvy year-end tax moves to consider now - Fidelity Investments
- Seven ways to prepare for tax changes
- Five reasons an annual review is crucial - Fidelity Investments
- Take a look at mid caps now - Fidelity Investments
- State of the sector: Health care - Fidelity Investments
VIDEO ON MSN MONEY
ABOUT
Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.
Contributors include professional investors and journalists affiliated with MSN Money.
Follow us on Twitter @topstocksmsn.
